Groupama Asset Managment »

Ultragenyx Pharmaceutical shares owned by Groupama Asset Managment

Quarter-by-quarter ownership of Ultragenyx Pharmaceutical (RARE) shares owned by Groupama Asset Managment from 13F filings

Historical chart of Groupama Asset Managment investment in Ultragenyx Pharmaceutical

Tip: Access up to 7 years of quarterly data

All positions including Ultragenyx Pharmaceutical held by Groupama Asset Managment consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ultragenyx Pharmaceutical by Groupama Asset Managment

Quarter filed Position value Share count Share price at filing
2024-09-30 $42k 948 44.60
2024-06-30 $30k 729 41.10

More positions owned by Groupama Asset Managment

Microsoft Corporation (MSFT)
Alnylam Pharmaceuticals (ALNY)
Cyberark Software SHS (CYBR)
Mongodb Cl A (MDB)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Insulet Corporation (PODD)
Akamai Technologies (AKAM)
Dex (DXCM)
Broadcom (AVGO)
Zscaler Incorporated (ZS)
Palo Alto Networks (PANW)
Alphabet Cap Stk Cl A (GOOGL)
Datadog Cl A Com (DDOG)
Amazon (AMZN)

View all positions for Groupama Asset Managment

Top funds holding Ultragenyx Pharmaceutical

Vanguard Group
BlackRock
Sands Capital Management
State Street Corporation
T. Rowe Price Associates
Wellington Management Company
ClearBridge Advisors
Federated Investors
Rtw Investments
Rock Springs Capital Management
Invesco
Deutsche Bank Aktiengesellschaft
Alkeon Capital Management
Alliancebernstein
Baker Bros. Advisors

View all funds holding Ultragenyx Pharmaceutical